Neonatal Male Circumcision Clinical Trial
Official title:
Feasibility, Acceptability, and Safety of Neonatal Male Circumcision at the University Teaching Hospital in Lusaka, Zambia and in the Lusaka District in Zambia Using Gomco; Plastibell; and Mogen Methods
Verified date | April 2010 |
Source | University of Alabama at Birmingham |
Contact | n/a |
Is FDA regulated | No |
Health authority | Zambia: Ministry of Health |
Study type | Interventional |
In this study of neonatal male circumcision (NMC), the investigators will examine acceptability of among parents, feasibility of training providers and implementing services in various clinical settings, and the safety of service provision comparing three different surgical methods: the Gomco; the Plastibell; and the Mogen clamp. This operational study is being conducted to inform the scale up of neonatal male circumcision in Zambia.
Status | Completed |
Enrollment | 661 |
Est. completion date | January 2012 |
Est. primary completion date | March 2011 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | N/A to 28 Days |
Eligibility |
Inclusion Criteria: - Male infants who are in the first day of life (including infants < 24 hours old) and up to 4 weeks of age will be considered for circumcision - Gestational age >37 weeks at birth Exclusion Criteria: - Any current illness - Bleeding diathesis or family history of bleeding disorder - Abnormality of urethra or penile shaft such as hypospadias - Local infection defined as redness, swelling, or a purulent discharge from the infant penis - Greater than four weeks of age |
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
Zambia | University Teaching Hospital and Matero Reference Clinic | Lusaka |
Lead Sponsor | Collaborator |
---|---|
University of Alabama at Birmingham | University Teaching Hospital, Lusaka, Zambia |
Zambia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Complication Rate | Includes intra-operative and post-operative complications such as bleeding, infection, and cosmetic problems | 0-6 weeks after the circumcision procedure | Yes |
Secondary | Uptake of NMC | Defined as % of parents of newborn boys approached during recruitment who consent to having their sons cirucumcised | Ongoing, over the course of the study (1.5 years) | No |
Secondary | Provider Preferences | Measure of provider preferences among 3 circumcision devices being compared | Upon completion of training in NMC | No |
Secondary | Parent Satisfaction | Score, between 0 and 100, of each parent's satisfaction with the outcome of the NMC procedure | 6 weeks following the circumcision procedure | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02596282 -
Enhanced Provision of Male Circumcision (MC) for HIV Prevention, Rakai, Uganda
|
Phase 2/Phase 3 |